Early identification and treatment of communication and swallowing deficits in parkinson disease

Seminars in Speech and Language

Volumn 34, Issue 3, 2013, Pages 185-202

  Ciucci, Micheller ^a,b   Grant, Lauram ^a,b   Rajamanickam, Eunices Paul ^a,b   Hilby, Breannal ^a,b   Blue, Katherinev ^a,b   Jones, Corinnea ^a,b   Kelm Nelson, Cynthiaa ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

communication; dysarthria; dysphagia; Parkinson disease; swallowing

Indexed keywords

COMMUNICATION DISORDER; DYSARTHRIA; DYSPHAGIA; EARLY DIAGNOSIS; HUMAN; PARKINSON DISEASE; PRACTICE GUIDELINE; REVIEW; SPEECH DISORDER;

COMMUNICATION DISORDERS; DEGLUTITION DISORDERS; DYSARTHRIA; EARLY DIAGNOSIS; HUMANS; PARKINSON DISEASE; PRACTICE GUIDELINES AS TOPIC; SPEECH-LANGUAGE PATHOLOGY;

EID: 84887012165     PISSN: 07340478     EISSN: 10989056     Source Type: Journal    
DOI: 10.1055/s-0033-1358367     Document Type: Article

References (101)

1. de Lau L. M., Giesbergen P. C., de Rijk M. C., Hofman A., Koudstaal P. J., Breteler M. M. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology: 2004; 63 7 1240 1244 (Pubitemid 39350024)
2. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci: 1973; 20 4 415 455
3. Braak H., Ghebremedhin E., Rüb U., Bratzke H., Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res: 2004; 318 1 121 134 (Pubitemid 39362633)
4. Hawkes C. H., Del Tredici K., Braak H. A timeline for Parkinson's disease. Parkinsonism Relat Disord: 2010; 16 2 79 84
5. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron: 2003; 39 6 889 909 (Pubitemid 37130207)
6. Michou E., Hamdy S. Dysphagia in Parkinson's disease: a therapeutic challenge? Expert Rev Neurother: 2010; 10 6 875 878
7. Bonifati V., Dekker M. C., Vanacore N., et al. Italian Parkinson Genetics Network. Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7. Neurol Sci: 2002; 23 02 S59 S60 (Pubitemid 35355776)
8. Guo J. F., Wang L., He D., et al. Clinical features and [11C]-CFT PET analysis of PARK2, PARK6, PARK7-linked autosomal recessive early onset Parkinsonism. Neurol Sci: 2011; 32 1 35 40
9. Logemann J. A., Fisher H. B., Boshes B., Blonsky E. R. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord: 1978; 43 1 47 57 (Pubitemid 8282392)
10. Trail M., Fox C., Ramig L. O., Sapir S., Howard J., Lai E. C. Speech treatment for Parkinson's disease. NeuroRehabilitation: 2005; 20 3 205 221 (Pubitemid 43086578)
11. Sapir S., Ramig L., Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg: 2008; 16 3 205 210 (Pubitemid 351677652)
12. Müller J., Wenning G. K., Verny M., et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol: 2001; 58 2 259 264 (Pubitemid 32163163)
13. Dickson J. M., Grünewald R. A. Somatic symptom progression in idiopathic Parkinson's disease. Parkinsonism Relat Disord: 2004; 10 8 487 492 (Pubitemid 39487196)
14. Volonté M. A., Porta M., Comi G. Clinical assessment of dysphagia in early phases of Parkinson's disease. Neurol Sci: 2002; 23 02 S121 S122 (Pubitemid 35355806)
15. Bird M. R., Woodward M. C., Gibson E. M., Phyland D. J., Fonda D. Asymptomatic swallowing disorders in elderly patients with Parkinson's disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients. Age Ageing: 1994; 23 3 251 254 (Pubitemid 24158297)
16. Potulska A., Friedman A., Królicki L., Spychala A. Swallowing disorders in Parkinson's disease. Parkinsonism Relat Disord: 2003; 9 6 349 353 (Pubitemid 36809036)
17. Mahler L., Ramig L. O., Logemann J., Halpern A. Description of subjective and objective swallow characteristics for people with PD. Poster session presented at: the International Movement Disorders Society; June 26, 2008; Chicago, IL
18. Miller N., Allcock L., Hildreth A. J., Jones D., Noble E., Burn D. J. Swallowing problems in Parkinson disease: frequency and clinical correlates. J Neurol Neurosurg Psychiatry: 2009; 80 9 1047 1049
19. Sung H. Y., Kim J. S., Lee K. S., et al. The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson's disease. Mov Disord: 2010; 25 14 2361 2368
20. Rusz J., Cmejla R., Ruzickova H., Ruzicka E. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease. J Acoust Soc Am: 2011; 129 1 350 367
21. Holmes R. J., Oates J. M., Phyland D. J., Hughes A. J. Voice characteristics in the progression of Parkinson's disease. Int J Lang Commun Disord: 2000; 35 3 407 418 (Pubitemid 30495290)
22. Stewart C., Winfield L., Hunt A., et al. Speech dysfunction in early Parkinson's disease. Mov Disord: 1995; 10 5 562 565
23. Harel B., Cannizzaro M., Snyder P. J. Variability in fundamental frequency during speech in prodromal and incipient Parkinson's disease: a longitudinal case study. Brain Cogn: 2004; 56 1 24 29 (Pubitemid 39223318)
24. Harel B. T., Cannizzaro M. S., Cohen H., Reilly N., Snyder P. J. Acoustic characteristics of Parkinsonian speech: a potential biomarker of early disease progression and treatment. J Neurolinguist: 2004; 17 439 453 (Pubitemid 39430334)
25. Rusz J., Cmejla R., Růžičková H., et al. Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy. J Neural Transm: 2013; 120 2 319 329
26. Illes J. Neurolinguistic features of spontaneous language production dissociate three forms of neurodegenerative disease: Alzheimer's, Huntington's, and Parkinson's. Brain Lang: 1989; 37 4 628 642 (Pubitemid 19275815)
27. Illes J., Metter E. J., Hanson W. R., Iritani S. Language production in Parkinson's disease: acoustic and linguistic considerations. Brain Lang: 1988; 33 1 146 160 (Pubitemid 18049751)
28. Ho A. K., Bradshaw J. L., Iansek R. For better or worse: the effect of levodopa on speech in Parkinson's disease. Mov Disord: 2008; 23 4 574 580
29. Kompoliti K., Wang Q. E., Goetz C. G., Leurgans S., Raman R. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology: 2000; 54 2 458 462 (Pubitemid 30078084)
30. Raskin S. A., Sliwinski M., Borod J. C. Clustering strategies on tasks of verbal fluency in Parkinson's disease. Neuropsychologia: 1992; 30 1 95 99
31. Tinaz S., Schendan H. E., Stern C. E. Fronto-striatal deficit in Parkinson's disease during semantic event sequencing. Neurobiol Aging: 2008; 29 3 397 407 (Pubitemid 351215589)
32. Zgaljardic D. J., Borod J. C., Foldi N. S., Mattis P. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol: 2003; 16 4 193 210 (Pubitemid 37517825)
33. Cooper J. A., Sagar H. J., Jordan N., Harvey N. S., Sullivan E. V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain: 1991; 114 Pt 5 2095 2122
34. Flowers K. A., Robertson C., Sheridan M. R. Some characteristics of word fluency in Parkinson's disease. J Neurolinguist: 1995; 9 1 33 46 (Pubitemid 126666331)
35. Lewis S. J., Dove A., Robbins T. W., Barker R. A., Owen A. M. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci: 2003; 23 15 6351 6356 (Pubitemid 36875637)
36. Kim Y., Kent R. D., Weismer G. An acoustic study of the relationships among neurologic disease, dysarthria type and severity of dysarthria. J Speech Lang Hear Res: 2011; 54 2 417 429
37. Miller N., Noble E., Jones D., Burn D. Hard to swallow: dysphagia in Parkinson's disease. Age Ageing: 2006; 35 6 614 618 (Pubitemid 44614157)
38. Ali G. N., Wallace K. L., Schwartz R., DeCarle D. J., Zagami A. S., Cook I. J. Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease. Gastroenterology: 1996; 110 2 383 392 (Pubitemid 26043870)
39. Troche M. S., Sapienza C. M., Rosenbek J. C. Effects of bolus consistency on timing and safety of swallow in patients with Parkinson's disease. Dysphagia: 2008; 23 1 26 32 (Pubitemid 351207622)
40. Leopold N. A., Kagel M. C. Laryngeal deglutition movement in Parkinson's disease. Neurology: 1997; 48 2 373 376
41. Leopold N. A., Kagel M. C. Pharyngo-esophageal dysphagia in Parkinson's disease. Dysphagia: 1997; 12 1 11 18, discussion 19-20
42. El Sharkawi A., Ramig L., Logemann J. A., et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. J Neurol Neurosurg Psychiatry: 2002; 72 1 31 36 (Pubitemid 34073092)
43. Fuh J. L., Lee R. C., Wang S. J., et al. Swallowing difficulty in Parkinson's disease. Clin Neurol Neurosurg: 1997; 99 2 106 112
44. Nagaya M., Kachi T., Yamada T., Igata A. Videofluorographic study of swallowing in Parkinson's disease. Dysphagia: 1998; 13 2 95 100 (Pubitemid 28122095)
45. Robbins J. A., Logemann J. A., Kirshner H. S. Swallowing and speech production in Parkinson's disease. Ann Neurol: 1986; 19 3 283 287 (Pubitemid 16111078)
46. Wintzen A. R., Badrising U. A., Roos R. A., Vielvoye J., Liauw L. Influence of bolus volume on hyoid movements in normal individuals and patients with Parkinson's disease. Can J Neurol Sci: 1994; 21 1 57 59 (Pubitemid 24090753)
47. Eadie M. J., Tyrer J. H. Alimentary disorder in Parkinsonism. Australas Ann Med: 1965; 14 13 22
48. Ertekin C., Tarlaci S., Aydogdu I., et al. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease. Mov Disord: 2002; 17 5 942 949 (Pubitemid 36040999)
49. Beyer M. K., Herlofson K., Årsland D., Larsen J. P. Causes of death in a community-based study of Parkinson's disease. Acta Neurol Scand: 2001; 103 1 7 11
50. D'Amelio M., Ragonese P., Morgante L., et al. Long-term survival of Parkinson's disease: a population-based study. J Neurol: 2006; 253 1 33 37 (Pubitemid 43157385)
51. Hely M. A., Reid W. GJ, Adena M. A., Halliday G. M., Morris J. GL. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord: 2008; 23 6 837 844
52. Plowman-Prine E. K., Sapienza C. M., Okun M. S., et al. The relationship between quality of life and swallowing in Parkinson's disease. Mov Disord: 2009; 24 9 1352 1358
53. Rosenbek J. C., Jones H. Dysphagia in Movement Disorders. San Diego, CA Plural Publishing: 2009
54. Baijens L. W., Speyer R. Effects of therapy for dysphagia in Parkinson's disease: systematic review. Dysphagia: 2009; 24 1 91 102
55. Pinto S., Ozsancak C., Tripoliti E., Thobois S., Limousin-Dowsey P., Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurol: 2004; 3 9 547 556 (Pubitemid 39485861)
56. De Letter M., Santens P., Estercam I., et al. Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners. Clin Linguist Phon: 2007; 21 10 783 791 (Pubitemid 47470819)
57. D'Alatri L., Paludetti G., Contarino M. F., Galla S., Marchese M. R., Bentivoglio A. R. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice: 2008; 22 3 365 372 (Pubitemid 351609321)
58. Pinto S., Thobois S., Costes N., et al. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study. Brain: 2004; 127 Pt 3 602 615 (Pubitemid 38295476)
59. Narayana S., Jacks A., Robin D. A., et al. A noninvasive imaging approach to understanding speech changes following deep brain stimulation in Parkinson's disease. Am J Speech Lang Pathol: 2009; 18 2 146 161
60. Sapir S., Spielman J. L., Ramig L. O., Story B. H., Fox C. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. J Speech Lang Hear Res: 2007; 50 4 899 912 (Pubitemid 350058568)
61. Ramig L. O., Sapir S., Fox C., Countryman S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls. Mov Disord: 2001; 16 1 79 83 (Pubitemid 36041117)
62. Russell J. A., Ciucci M. R., Connor N. P., Schallert T. Targeted exercise therapy for voice and swallow in persons with Parkinson's disease. Brain Res: 2010; 1341 3 11
63. Schulz G. M., Grant M. K. Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: a review of the literature. J Commun Disord: 2000; 33 1 59 88 (Pubitemid 30067615)
64. Gallena S., Smith P. J., Zeffiro T., Ludlow C. L. Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease. J Speech Lang Hear Res: 2001; 44 6 1284 1299 (Pubitemid 34008277)
65. Ramig L. O., Verdolini K. Treatment efficacy: voice disorders. J Speech Lang Hear Res: 1998; 41 1 S101 S116 (Pubitemid 28081267)
66. Herd C. P., Tomlinson C. L., Deane K. H., et al. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease. Cochrane Database Syst Rev: 2012; 8 CD002814
67. Ramig L. O., Countryman S., O'Brien C., Hoehn M., Thompson L. Intensive speech treatment for patients with Parkinson's disease: short-and long-term comparison of two techniques. Neurology: 1996; 47 6 1496 1504 (Pubitemid 26422543)
68. Baumgartner C. A., Sapir S., Ramig T. O. Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease. J Voice: 2001; 15 1 105 114 (Pubitemid 32231496)
69. Ramig L. O., Sapir S., Countryman S., et al. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2. year follow up. J Neurol Neurosurg Psychiatry: 2001; 71 4 493 498 (Pubitemid 32906873)
70. Spielman J., Ramig L. O., Mahler L., Halpern A., Gavin W. J. Effects of an extended version of the Lee Silverman voice treatment on voice and speech in Parkinson's disease. Am J Speech Lang Pathol: 2007; 16 2 95 107
71. Searl J., Wilson K., Haring K., Dietsch A., Lyons K., Pahwa R. Feasibility of group voice therapy for individuals with Parkinson's disease. J Commun Disord: 2011; 44 6 719 732
72. Narayana S., Fox P. T., Zhang W., et al. Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis. Hum Brain Mapp: 2010; 31 2 222 236
73. Cannito M. P., Suiter D. M., Beverly D., Chorna L., Wolf T., Pfeiffer R. M. Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease. J Voice: 2012; 26 2 214 219
74. Ciucci M. R., Barkmeier-Kraemer J. M., Sherman S. J. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease. Mov Disord: 2008; 23 5 676 683
75. Lengerer S., Kipping J., Rommel N., et al. Deep-brain-stimulation does not impair deglutition in Parkinson's disease. Parkinsonism Relat Disord: 2012; 18 7 847 853
76. Logemann J. A., Gensler G., Robbins J., et al. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease. J Speech Lang Hear Res: 2008; 51 1 173 183 (Pubitemid 351206583)
77. Pitts T., Bolser D., Rosenbek J., Troche M., Okun M. S., Sapienza C. Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest: 2009; 135 5 1301 1308
78. Troche M. S., Okun M. S., Rosenbek J. C., et al. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology: 2010; 75 21 1912 1919
79. Manor Y., Mootanah R., Freud D., Giladi N., Cohen J. T. Video-assisted swallowing therapy for patients with Parkinson's disease. Parkinsonism Relat Disord: 2013; 19 2 207 211
80. Speyer R., Baijens L., Heijnen M., Zwijnenberg I. Effects of therapy in oropharyngeal dysphagia by speech and language therapists: a systematic review. Dysphagia: 2010; 25 1 40 65
81. Konerth M., Childers J. Exercise: a possible adjunct therapy to alleviate early Parkinson disease. JAAPA: 2013; 26 4 30 33
82. Smith M. E., Ramig L. O., Dromey C., Perez K. S., Samandari R. Intensive voice treatment in Parkinson disease: laryngostroboscopic findings. J Voice: 1995; 9 4 453 459
83. Elefant C., Baker F. A., Lotan M., Lagesen S. K., Skeie G. O. The effect of group music therapy on mood, speech, and singing in individuals with Parkinson's disease-a feasibility study. J Music Ther: 2012; 49 3 278 302
84. Cruise K. E., Bucks R. S., Loftus A. M., Newton R. U., Pegoraro R., Thomas M. G. Exercise and Parkinson's: benefits for cognition and quality of life. Acta Neurol Scand: 2011; 123 1 13 19
85. Haneishi E. Effects of a music therapy voice protocol on speech intelligibility, vocal acoustic measures, and mood of individuals with Parkinson's disease. J Music Ther: 2001; 38 4 273 290 (Pubitemid 33649626)
86. de Angelis E. C., Mourão L. F., Ferraz H. B., Behlau M. S., Pontes P. A., Andrade L. A. Effect of voice rehabilitation on oral communication of Parkinson's disease patients. Acta Neurol Scand: 1997; 96 4 199 205 (Pubitemid 27402486)
87. Aminoff M. J., Christine C. W., Friedman J. H., et al. National Parkinson Foundation Working Group on Hospitalization in Parkinson's Disease. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord: 2011; 17 3 139 145
88. Smith S. K., Roddam H., Sheldrick H. Rehabilitation or compensation: time for a fresh perspective on speech and language therapy for dysphagia and Parkinson's disease? Int J Lang Commun Disord: 2012; 47 4 351 364
89. Melo A., Monteiro L. Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence. Parkinsonism Relat Disord: 2013; 19 3 279 281
90. Deane K. H., Whurr R., Clarke C. E., Playford E. D., Ben-Shlomo Y. Non-pharmacological therapies for dysphagia in Parkinson's disease. Cochrane Database Syst Rev: 2001; 1 CD002816
91. Van Lieshout P. H., Steele C. M., Lang A. E. Tongue control for swallowing in Parkinson's disease: effects of age, rate, and stimulus consistency. Mov Disord: 2011; 26 9 1725 1729
92. South A. R., Somers S. M., Jog M. S. Gum chewing improves swallow frequency and latency in Parkinson patients: a preliminary study. Neurology: 2010; 74 15 1198 1202
93. Bushmann M., Dobmeyer S. M., Leeker L., Perlmutter J. S. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology: 1989; 39 10 1309 1314 (Pubitemid 19246802)
94. Felix V. N., Corrêa S. M., Soares R. J. A therapeutic maneuver for oropharyngeal dysphagia in patients with Parkinson's disease. Clinics (Sao Paulo): 2008; 63 5 661 666
95. Nagaya M., Kachi T., Yamada T. Effect of swallowing training on swallowing disorders in Parkinson's disease. Scand J Rehabil Med: 2000; 32 1 11 15
96. Robertson S. J., Thomson F. Speech therapy in Parkinson's disease: a study of the efficacy and long term effects of intensive treatment. Br J Disord Commun: 1984; 19 3 213 224 (Pubitemid 15196677)
97. Hunter P. C., Crameri J., Austin S., Woodward M. C., Hughes A. J. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry: 1997; 63 5 579 583 (Pubitemid 27489220)
98. Heijnen B. J., Speyer R., Baijens L. W., Bogaardt H. C. Neuromuscular electrical stimulation versus traditional therapy in patients with Parkinson's disease and oropharyngeal dysphagia: effects on quality of life. Dysphagia: 2012; 27 3 336 345
99. Baijens L. W., Speyer R., Passos V. L., Pilz W., Roodenburg N., Clavé P. The effect of surface electrical stimulation on swallowing in dysphagic Parkinson patients. Dysphagia: 2012; 27 4 528 537
100. Regan J., Walshe M., Tobin W. O. Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson's disease. Dysphagia: 2010; 25 3 207 215
101. Robertson S. J., ed. Robertson Dysarthria Proflile. Bicester, UK Winslow Press: 1982